tiprankstipranks
Humacyte (HUMA)
NASDAQ:HUMA
US Market

Humacyte (HUMA) Ownership - Who Owns Humacyte?

404 Followers

Humacyte (HUMA) Ownership Overview

20.74%4.01%9.59%65.66%
20.74% Insiders
9.59% Other Institutional Investors
65.66% Public Companies and
Individual Investors
The ownership structure of Humacyte (HUMA) stock is a mix of institutional, retail and individual investors. Approximately 13.60% of the company’s stock is owned by Institutional Investors, 20.74% is owned by Insiders and 65.66% is owned by Public Companies and Individual Investors.
The ownership structure of Humacyte (HUMA) stock is a mix of institutional, retail and individual investors. Approximately 13.60% of the company’s stock is owned by Institutional Investors, 20.74% is owned by Insiders and 65.66% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 21, 2023Bought$7811
Oct 10, 2023
Laura E Niklason
Pres, Ceo & Dir,director
Bought$136160
Oct 10, 2023Bought$136160
Sep 15, 2023
Laura E Niklason
Pres, Ceo & Dir,director
Sold$5560000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$93455
Dec 31, 2023Bought$367084

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,795,695Institution3.19%20,800,409
3,002,946Institution2.52%16,456,144
2,467,751Institution2.07%13,523,275
661,602Institution0.56%3,625,579
630,754Institution0.53%3,456,532
311,902Institution0.26%1,709,223
278,984Institution0.23%1,528,832
230,164Institution0.19%1,261,299
162,560Institution0.14%890,829
151,968Institution0.13%832,785

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,467,751Institution2.07%13,523,275
661,602Institution0.56%3,625,579
630,754Institution0.53%3,456,532
278,984Institution0.23%1,528,832
230,164Institution0.19%1,261,299
162,560Institution0.14%890,829
80,338Institution0.07%440,252
32,332Institution0.03%177,179
28,356Institution0.02%155,391
27,732Institution0.02%151,971

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,459,745Institution1.23%7,999,403
2,387,975Institution2.01%7,426,602
595,857Institution0.50%3,265,296
891,611Institution0.75%2,772,910
467,787Institution0.39%2,563,473
289,189Institution0.24%1,359,188
130,909Institution0.11%717,381
229,726Institution0.19%714,448
228,317Institution0.19%710,066
116,393Institution0.10%637,834

FAQ

Who Owns Humacyte (HUMA)?
According to the latest TipRanks data, approximately 9.59% of the company's stock is held by institutional investors, 20.74% is held by insiders, and 65.66% is held by retail investors.
    What percentage of Humacyte (HUMA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 9.59% of Humacyte (HUMA) stock is held by institutional investors.
      What percentage of Humacyte (HUMA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 65.66% of Humacyte (HUMA) stock is held by retail investors.
        Who owns the most shares of Humacyte (HUMA)?
        Vanguard owns the most shares of Humacyte (HUMA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis